http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105213370-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2014-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105213370-B |
| titleOfInvention | The application of phthalide compound |
| abstract | It is a kind of to use phthalide compound（phthalide）In the purposes for preparing medicament, which is especially to treat and/or delay Purkinje cell（Purkinje cells）It degenerates, and the phthalide compound is to be selected from following group：Butylidenephthalide, the metabolism predecessor of butylidenephthalide, the medical acceptable salt of metabolism predecessor of butylidenephthalide, the medical acceptable ester for being metabolized predecessor of butylidenephthalide and arbitrary combination above-mentioned. |
| priorityDate | 2014-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 148.